Compare BN & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BN | ELV |
|---|---|---|
| Founded | 1997 | 1944 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.9B | 96.6B |
| IPO Year | 1998 | 2001 |
| Metric | BN | ELV |
|---|---|---|
| Price | $41.45 | $428.20 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 22 |
| Target Price | $53.75 | ★ $482.38 |
| AVG Volume (30 Days) | ★ 5.2M | 1.4M |
| Earning Date | 11-12-2026 | 10-21-2026 |
| Dividend Yield | 0.65% | ★ 1.59% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 21.01 |
| Revenue | N/A | ★ $199,125,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $22.72 | $2.46 |
| P/E Ratio | $93.92 | ★ $20.67 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $35.61 | $274.89 |
| 52 Week High | $49.57 | $450.69 |
| Indicator | BN | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 62.72 | 54.10 |
| Support Level | $35.99 | $373.93 |
| Resistance Level | $45.00 | $430.13 |
| Average True Range (ATR) | 1.10 | 14.27 |
| MACD | 0.50 | -0.76 |
| Stochastic Oscillator | 69.26 | 46.97 |
Brookfield Corp is an investment firm focused on building long-term wealth for institutions and individuals, operating through seven segments: Asset Management, Wealth Solutions, Renewable Power and Transition, Infrastructure, Private Equity (which generates the highest revenue), Real Estate, and Corporate Activities. The company invests in real assets that form the backbone of the economy to deliver risk-adjusted returns to stakeholders, with the majority of its revenue coming from Asset Management. It has a presence across the United Kingdom, the United States (which contributes the highest revenue), Australia, Canada, Brazil, India, Colombia, Germany, other parts of Europe, other parts of Asia, and additional countries.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.